Displaying drugs 9226 - 9250 of 9920 in total
Zinc glycinate citrate
Experimental
Methacrylyl-Coenzyme A
Experimental
Glutathione S-atrazine
Experimental
CoA-s-acetyl tryptamine
Experimental
S-P-Nitrobenzyloxycarbonylglutathione
Experimental
3-Hydroxybutyryl-Coenzyme A
Experimental
Olcegepant
Boehringer Ingelheim Pharmaceuticals’ olcegepant (BIBN 4096) is a selective Calcitonin Gene-Related Peptide (CGRP) antagonist, a new class of drugs in development for the treatment of acute migraine attacks. Olcegepant is undergoing phase II trials in Europe and the US, with preliminary results suggesting that CGRP antagonists may represent a potential...
Investigational
Nitromethyldethia coenzyme A
Experimental
Etarfolatide
Etarfolatide has been used in trials studying the treatment and diagnostic of Breast Neoplasms, Non Small Cell Lung Cancer, and Adenocarcinoma of the Lung.
Investigational
TAK-448
TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.
Investigational
TRV-120027
TRV120027 has been used in trials studying the treatment of Heart Failure and Kidney Disease.
Investigational
Proglumetacin
Experimental
Hydroxyethylcysteine
Experimental
Ulapualide A
Experimental
2-Iminobiotin
Experimental
Investigational
(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid
(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is a solid. This compound belongs to the indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is known to target interleukin-2.
Experimental
Anacetrapib
Investigational
Lucitanib
Lucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others.
Investigational
Displaying drugs 9226 - 9250 of 9920 in total